Clinical Trials in Detroit

Showing 11581-11600 of 19,719 trials

Dehydration and Population Health

NCT04502238

The primary aim of this study is to assess cardiovascular changes (blood pressure, heart rate, electrocardiogram/ECG) in response to mild fluid-restriction dehydration and subsequent rehydration in healthy young and old people. Secondary aims are to assess changes in body composition, mood, and hunger in response to mild dehydration and rehydration.

Dehydration (Physiology)

Wayne State University40 participantsStarted Mar 2020

Detroit, Michigan, United States

COMPLETEDPhase 2< 1 mile

Study of Regorafenib for Urothelial Cancer Following Chemotherapy (UAB 1477)

NCT02459119

This study will test how well Regorafenib controls disease progression in urothelial cancer (cancer occurring in the urinary bladder, ureters, or renal pelvis) following previous therapy with chemotherapy.

Urothelial Cancer (Urinary Bladder, Ureters, or Renal Pelvis Cancer)

University of Alabama at Birmingham17 participantsStarted May 2015

Birmingham, Alabama, United States • Detroit, Michigan, United States • Cleveland, Ohio, United States

COMPLETED< 1 mile

Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma

NCT03628651

The primary objective of this study is to obtain de-identified, clinically-characterized whole blood specimens for use in developing and evaluating the performance of new biomarker assays for detection of hepatocellular carcinoma (HCC).

Hepatocellular CarcinomaHepatocellular Carcinoma Surveillance

Exact Sciences Corporation2,150 participantsStarted Apr 2018

Los Angeles, California, United States • Los Angeles, California, United States • Newport Beach, California, United States +71 more locations

Dehydration and Population Health

Study of Regorafenib for Urothelial Cancer Following Chemotherapy (UAB 1477)

Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma

Find Trials by Condition in Detroit

Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS)

A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas.

Efficacy and Safety of Intravenous Neridronic Acid in CRPS

Efficacy and Safety of Intravenous Neridronic Acid in Complex Regional Pain Syndrome (CRPS)

Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis

A Study of OMP-305B83 in Subjects With Metastatic Colorectal Cancer

Mechanistic Study of Duloxetine in Breast Cancer Patients With Chronic Pain

PRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH)

A Rollover Safety Study of Lumacaftor/Ivacaftor in Subjects Aged 2 Years and Older With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation

Self-management to Improve Function Following Amputation

Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Manufacturing Technology

Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma

Study of the Native Outflow Tract Transcatheter Pulmonary Valve (TPV)

A Study to Assess the Efficacy and Safety of Abatacept in Adults With Active Primary Sjögrens Syndrome

Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic Melanoma

Alpha Lipoic Acid in Geographic Atrophy

Enzastaurin in Combination of Capecitabine to Treat Breast Cancer